Prior to publication of the final evidence report, EPCs sought input from independent Peer Reviewers without financial conflicts of interest. However, the conclusions and synthesis of the scientific literature presented in this report do not necessarily represent the views of individual reviewers. AHRQ may also seek comments from other Federal agencies when appropriate.

Peer Reviewers must disclose any financial conflicts of interest greater than $5,000 and any other relevant business or professional conflicts of interest. Because of their unique clinical or content expertise, individuals with potential nonfinancial conflicts may be retained. The TOO and the EPC work to balance, manage, or mitigate any potential nonfinancial conflicts of interest identified.

The list of Peer Reviewers follows:

• Jill Dietz, M.D., M.H.C.M., FACS
  Breast Surgeon
  Allegheny Health Network Cancer Institute
  Pittsburgh, PA
• Elizabeth M. Nichols, M.D.
  Associate Professor of Radiation Oncology
  University of Maryland School of Medicine
  Baltimore, MD
• Jean L. Wright, M.D.
  Director of Breast Cancer Program and Associate Professor of Radiation Oncology and Molecular Radiation Sciences
  Johns Hopkins University School of Medicine
  Baltimore, MD
• Richard Zellars, M.D.
  Professor and Chair of the Department of Radiation Oncology
  Indiana University School of Medicine
  Indianapolis, IN